Results 81 to 90 of about 8,326 (289)

Possibilities of Inner Ear Barrier Models for Otologic Drug Development

open access: yesAdvanced Therapeutics, Volume 8, Issue 11, November 2025.
This review examines innovative organ chip models that reconstruct critical inner ear barriers, addressing a fundamental challenge in otologic drug development: the limited understanding of pharmaceutical behavior across these complex barriers. By replicating these barriers, the advanced models offer promising alternatives to traditional testing ...
Yeji Ahn   +7 more
wiley   +1 more source

In Children With Effusion Do Topical Antibiotics at Tympanostomy Tube Reduce Postoperative Otorrhea?

open access: yes
The Laryngoscope, Volume 136, Issue 2, Page 533-534, February 2026.
Holly Jones   +4 more
wiley   +1 more source

The Behavioral Phenotype and Importance of Multidisciplinary Care in Patients With Sotos Syndrome: A Single‐Center Experience

open access: yesAmerican Journal of Medical Genetics Part A, Volume 197, Issue 11, November 2025.
ABSTRACT Sotos syndrome is an autosomal dominant condition caused by pathogenic variants in the NSD1 gene on chromosome 5q35. It is characterized by macrosomia, distinctive facial features, and developmental delays. Patients are also reported to have a behavioral phenotype including autism spectrum disorder, attention deficit/hyperactivity disorder ...
Aravind Viswanathan   +4 more
wiley   +1 more source

Comparison of Rate of Recurrence of Otitis Media with Effusion(Otorrhea) in Patients Treated by Myringotomy and Tympanostomy Tubes with Patients Treated by Additional Adenoidectomy

open access: yesJournal of Rawalpindi Medical College, 2014
Background: To compare the frequency of recurrence of otitis media with effusion in patients treated by myringotomy and tympanostomy tube insertion with patients treated by adenoidectomy, myringotomy and tympanostomy tubes.
Nighat Arif,
doaj  

Mnlticentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children [PDF]

open access: yes, 2017
A total of 389 children (age 0.6-10.2 years) with typical signs and symptoms of acute otitis media were randomized (1:1) to treatment with either azithromycin or co-amoxiclav. The dosage schedule for azithromycin was 10 mg/kg/day, in a single daily dose,
Schaad, U. B.
core  

Major surgery within the first 3 months of life and subsequent biobehavioral pain responses to immunization at later age: A case comparison study. [IF 3.4] [PDF]

open access: yes, 2003
Objectives. Pain exposure during early infancy affects the pain perception beyond infancy into childhood. The objective of this study was to examine whether major surgery within the first 3 months of life in combination with preemptive analgesia alters ...
Boer, J.B. de   +7 more
core   +2 more sources

Mucopolysaccharidosis Type IIIB With Pancytopenia: A Case Report and Hematological Correlations in Mice

open access: yesClinical Genetics, Volume 108, Issue 5, Page 604-608, November 2025.
We report an individual with mucopolysaccharidosis type IIIB and chronic pancytopenia. Hematological studies in a mouse model revealed microcytic anemia and decreased monocyte count. Hence, pancytopenia is thought to be secondary to mucopolysaccharidosis type IIIB, and we suggest that a complete blood count should be included in the clinical ...
Éliane Beauregard‐Lacroix   +3 more
wiley   +1 more source

Syringosubarachnoid shunting using a myringotomy tube

open access: yesSurgical neurology international, 2016
Background: Syringomyelia results from obstruction of cerebrospinal fluid (CSF) flow due to a multitude of causes. Often symptoms of pain, weakness, and sensory disturbance are progressive and require surgical treatment.
Jack Leschke   +2 more
semanticscholar   +1 more source

Pain score guided morphine titration is risky and inappropriate [PDF]

open access: yes, 2014
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106691/1/pan12367 ...
Malviya, Shobha, Voepel‐lewis, Terri
core   +1 more source

Targeting Neutrophil/Eosinophil Extracellular Traps by Aptamer‐Functionalized Nanosheets to Overcome Recalcitrant Inflammatory Disorders

open access: yesAdvanced Science, Volume 12, Issue 38, October 13, 2025.
In this study, C‐TAH, as multifunctional nanosheets, is developed with tannic acid and histone aptamer coverage. C‐TAH displays mild cytotoxicity, robust dsDNA and NETs/EETs binding efficiency, and potent antioxidant and antibacterial ability in vitro. C‐TAH treatment ameliorates dysregulated inflammation and restores hearing function in animal models,
Yongqiang Xiao   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy